Abstract:Background: Ventricular septal defect (VSD) is the most common congenital cardiac malformation, accounting for approximately 30% of congenital heart defects. Conventional surgical repair using cardiopulmonary bypass is invasive and associated with morbidities and prolonged hospital stay. With the advent of interventional approaches and availability of different occluding devices, the technique of perventricular device closure is evolving and being implemented successfully in larger groups of patients. We present herein, our initial experience of perventricular device closure for the ventricular septal defects in children to assess risks and benefits. Methods: From March, 2023 to February, 2024, we have performed perventricular closure of ventricular septal defects in 13 children, under guidance of transesophageal echocardiography without cardiopulmonary bypass support. The median age at operation was 2 year (range 1.3-10 years) with the median body weight 11 kg (range 8.7-16.6 kg). Sixty-nine percent were males. The ventricular septal defect sizes ranged from 2.7 to 6 mm (mean 4.7 mm). Seven defects were perimembranous, four sub-aortic and two were muscular. One patient also underwent pulmonary artery de-banding with pulmonary artery balloon angioplasty and other one patent ductus arteriosus ligation, concomitantly. For defect closure, we used ventricular septal defect occlusion device (MemoPart™, Lepu Medical Technology Company, China) through a 3-cm skin incision in the lower- third of the sternum. The device sizes ranged from 5 to 8 mm (mean 6.9+-1.8 mm) and all patients except for two required symmetrical devices. Results: All patients underwent device closure successfully. The procedural duration ranged between 32 and 52 min. None of the patients required cardiopulmonary bypass. The mean ventilation time and intensive care unit stay was 3 and 24 h, respectively. None of the patients required inotropic support or blood transfusions. Moreover, no patients developed any arrhythmias including heart block. The average length of hospital stay was 4.4 days. At the latest follow up, there were no residual shunts, conduction disturbances, device dislodgement or major aortic or tricuspid valve complications seen in any patients. There was no mortality. Conclusions: Perventricular device closure of ventricular septal defects is a less invasive, extremely safe and effective method in children. It is associated with very fast recovery, shorter hospitalization time and better cosmetic incision. Moreover, it avoids cardiopulmonary bypass. The modifications and refinements in the design, material and implantation techniques will help in expanding the indications and prevent complications in the long-term.

Midterm Results Comparing Perventricular Device Closure with Surgical Repair for Isolated Congenital Ventricular Septal Defects: A Systematic Review and Meta-Analysis

Minimally Invasive Perventricular Device Closure of Perimembranous Ventricular Septal Defect Without Cardiopulmonary Bypass: Multicenter Experience and Mid-Term Follow-Up

Minimally Invasive Experiences on Perventricular Device Closure of Ventricular Septal Defects in Children

Perimembranous Ventricular Septal Defect Closure Via Ultra-Minimal Trans Intercostal Incision in Children.

A Study on Eccentric Occluder Via Ultra Minimal Incision of Doubly Committed Subarterial Ventricular Septal Defects

Doubly Committed Ventricular Septal Defect Closure Using Eccentric Occluder Via Ultraminimal Incision

A meta-analysis of perventricular device closure of perimembranous ventricular septal defect

Hybrid perventricular device closure of doubly committed subarterial ventricular septal defects: mid-term results.

Analysis and Comparison of Failure Causes of Minimally Invasive Surgical Closure of Ventricular Septal Defects in Children

Minimally invasive perventricular device closure of doubly committed sub-arterial ventricular septal defects: single center long-term follow-up results

Perventricular device closure of the ventricular septal defects in children-first experience in the United Arab Emirates

Comparison of Results and Economic Analysis of Surgical and Transcatheter Closure of Perimembranous Ventricular Septal Defect.

Preliminary Surgical Experience of Minimally Invasive Device Closure of Perimembranous Ventricular Septal Defects

Transcatheter Device Closure of Perimembranous and Intracristal Ventricular Septal Defects in Children: Medium‐ and Long‐Term Results

Hybrid Transthoracic Periventricular Device Closure of Ventricular Septal Defects: Single- Center Experience

Minimally Invasive Perventricular Versus Open Surgical Ventricular Septal Defect Closure in Infants and Children: a Randomised Clinical Trial

A Systematic Review on the Efficacy and Safety of Transcatheter Device Closure of Ventricular Septal Defects (VSD)

Perventricular device closure of ventricular septal defects: six months results in 30 young children.

Perventricular Device Closure of Perimembranous Ventricular Septal Defect in Pediatric Patients: Technical and Morphological Considerations

Comparison of transcatheter closure, mini-invasive closure, and open-heart surgical repair for treatment of perimembranous ventricular septal defects in children: A PRISMA-compliant network meta-analysis of randomized and observational studies.

Results of Two Different Approaches to Closure of Subaortic Ventricular Septal Defects in Children.